UiPath Officer Files Intent to Sell $171K in Stock Under 10b5-1 Plan
UiPath, Inc.
Subscribe to track PATH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
UiPath Officer Files Intent to Sell $171K in Stock
Company: UiPath, Inc. (Ticker: N/A) Form: 144 | Filed: 2025-10-14 Significance: Low
Insider: Hitesh Ramani Title: Not Disclosed | Relationship: Officer
Transaction: • Type: Proposed Sale (10b5-1 Plan) • Shares: 10,000 • Approx. Price: $17.14 • Value: $171,400 • Owned After: Not Disclosed
Key Insight: An officer has filed a notice of a proposed sale of shares, acquired via RSUs, under a pre-arranged 10b5-1 trading plan established in July 2025.
Market Context: This is a planned sale, which typically carries less weight than a spontaneous open-market transaction. The value is minor relative to the company's market cap.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: UiPath, Inc. (N/A)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer of UiPath, Inc. has filed a Form 144, signaling intent to sell 10,000 shares of common stock valued at approximately $171,400. The sale is scheduled under a pre-established 10b5-1 trading plan, which significantly reduces its market signaling power.
- Market Impact: The impact on the stock is expected to be neutral. The sale is relatively small in value and was pre-planned, suggesting it is likely for personal financial management rather than a change in the insider's outlook on the company's future.
Company Information
| Field | Value |
|---|---|
| Company | UiPath, Inc. |
| Ticker Symbol | Not provided in filing |
| CIK | 0001734722 |
| Industry | SERVICES-PREPACKAGED SOFTWARE [7372] |
Insider Information
| Field | Value |
|---|---|
| Name | Hitesh Ramani |
| CIK | 0001855764 |
| Title/Position | Not Disclosed |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 (Notice of Proposed Sale) |
| Transaction Date | Approx. 10/14/2025 |
| Transaction Code | Not Applicable |
| Security Type | Common Stock |
| Shares Involved | 10,000 |
| Price Per Share | Approx. $17.14 (calculated) |
| Total Value | $171,400.00 |
| Shares Owned After | Not Disclosed |
| Ownership Type | Not Disclosed |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Form 144 filings for sales under a 10b5-1 plan are routine for corporate insiders. The plan was adopted on July 14, 2025, well in advance of the proposed sale date. This indicates the transaction is not based on recent, non-public information. The total value of the sale is not substantial enough to materially affect a company of UiPath's size.
Volume & Sentiment
- Expected Volume Impact: Minimal. The transaction size is unlikely to cause a noticeable spike in trading volume.
- Sentiment Indicator: Neutral. The market generally views pre-planned 10b5-1 sales as non-events unless they are exceptionally large or part of a broader pattern of selling by multiple insiders.
Investment Insights
Positive Market Indicators
- The use of a 10b5-1 plan demonstrates orderly and transparent financial planning by the insider, which is a corporate governance positive.
Risk Factors
- While this single transaction is not a concern, investors should monitor if this is the beginning of a pattern of sales by this insider or other executives.
Key Takeaways
- Pre-Planned Sale: The transaction is being executed under a 10b5-1 trading plan, indicating it was scheduled in advance.
- Low Monetary Significance: The total value of $171,400 is a minor amount for a corporate officer and for the company's overall market capitalization.
- Source of Shares: The filing notes the securities were acquired from the vesting of Restricted Stock Units (RSUs), a common form of executive compensation. Selling vested shares is a normal part of personal asset diversification and tax planning.
Contextual Analysis
Timing Significance
The proposed sale date is October 14, 2025, with the filing made on the same day. The key timing element is the 10b5-1 plan adoption date of July 14, 2025, which provides a three-month cooling-off period before the proposed sale, reinforcing the planned nature of the event.
Transaction Context
The filing is a 'Notice of Proposed Sale of Securities', not a confirmation of a completed sale. The insider also reported a sale of 10,000 shares for $170,056 on the previous day (10/13/2025) under a 10b5-1 plan, suggesting these are regular, scheduled dispositions.
Company Context
Without recent news or earnings reports provided, the analysis is limited to the filing itself. This transaction should be viewed in the context of UiPath's stock performance and recent corporate developments around the transaction date.
Risk Assessment
Risk Level: Low
Risk Factors
- This filing, in isolation, presents a very low risk to investors.
- The primary risk would be if this sale precedes negative company news, which would undermine the 'pre-planned' nature in the eyes of the market, but there is no indication of that here.
Market Considerations
- Automated trading algorithms are unlikely to react negatively to this type of filing.
- The filing provides transparency into an insider's planned actions, which is a net positive for market information.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-14 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
